U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Tue Apr 01 19:27:30 GMT 2025
Edited
by admin
on Tue Apr 01 19:27:30 GMT 2025
Protein Type RECEPTOR
Protein Sub Type TYROSINE KINASE
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
4796L35A70
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CD135
Preferred Name English
RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3
Common Name English
FLT3
Common Name English
FETAL LIVER KINASE-2
Common Name English
FMS-LIKE TYROSINE KINASE 3
Common Name English
FLK2
Common Name English
FL CYTOKINE RECEPTOR
Common Name English
FLT-3
Common Name English
STEM CELL TYROSINE KINASE 1
Common Name English
Code System Code Type Description
PHAROS
P36888
Created by admin on Tue Apr 01 19:27:30 GMT 2025 , Edited by admin on Tue Apr 01 19:27:30 GMT 2025
PRIMARY
FDA UNII
4796L35A70
Created by admin on Tue Apr 01 19:27:30 GMT 2025 , Edited by admin on Tue Apr 01 19:27:30 GMT 2025
PRIMARY
UNIPROT
P36888
Created by admin on Tue Apr 01 19:27:30 GMT 2025 , Edited by admin on Tue Apr 01 19:27:30 GMT 2025
PRIMARY
From To
1_9 1_39
1_77 1_88
1_173 1_180
1_206 1_215
1_246 1_304
1_342 1_381
1_355 1_366
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_17
N 1_74
N 1_125
N 1_280
N 1_297
N 1_325
N 1_328
N 1_447
N 1_476
N 1_515
Related Record Type Details
Structure of ILORASERTIB
INHIBITOR -> TARGET
Structure of PF-06273340
INHIBITOR->OFF-TARGET
Structure of MIVAVOTINIB
INHIBITOR -> TARGET
Structure of Denfivontinib
INHIBITOR -> TARGET
Structure of PACRITINIB
INHIBITOR -> TARGET
IC50
Structure of SUNITINIB
INHIBITOR -> TARGET
Structure of FN-1501
INHIBITOR -> TARGET
Structure of KW-2449
INHIBITOR -> TARGET
Structure of LESTAURTINIB
INHIBITOR -> TARGET
Structure of FEDRATINIB
INHIBITOR -> TARGET
Structure of Ruserontinib
INHIBITOR -> TARGET
IC50
Structure of MRX-2843
INHIBITOR -> TARGET
IC50
Structure of BPR-1K871
INHIBITOR -> TARGET
Structure of GILTERITINIB
INHIBITOR -> TARGET
Structure of MIDOSTAURIN
INHIBITOR -> TARGET
Structure of JAK-IN-28
INHIBITOR -> TARGET
Structure of Tuspetinib
INHIBITOR -> TARGET
ALSO ACTIVE AGAINST FLT3 ITD and FLT3 D835Y kinases were 1.8 nM and 1.0 nM
Structure of Lsmotinib
INHIBITOR -> TARGET
Structure of CGP-52421
INHIBITOR -> TARGET
Structure of CEP-11981
INHIBITOR -> TARGET
IC50
Structure of Dapolsertib
INHIBITOR -> TARGET
Kd
Structure of NINGETINIB
INHIBITOR -> TARGET
IC50
Emirodatamab
LIGAND->TARGET
Structure of BMS-794833
INHIBITOR -> TARGET
IC50
Structure of PEXIDARTINIB
INHIBITOR -> TARGET
IC50
Structure of TANDUTINIB
INHIBITOR -> TARGET
Structure of LUXEPTINIB
INHIBITOR -> TARGET
ALSO ACTIVE AGAINST FLT3-ITD mutants
IC50
Structure of JNJ-28312141 FREE BASE
INHIBITOR -> TARGET
Structure of Mobinitinib
INHIBITOR -> TARGET
Structure of CGP-62221
INHIBITOR -> TARGET
Structure of SORAFENIB
INHIBITOR -> TARGET
Structure of TSN-084
INHIBITOR -> TARGET
PRECLINICAL
Structure of Flonoltinib
INHIBITOR -> TARGET
IC50
Structure of CENISERTIB
INHIBITOR -> TARGET
COMPETITIVE INHIBITOR
IC50
Structure of Nefextinib
INHIBITOR -> TARGET
Structure of IDRX-42
INHIBITOR -> TARGET
IC50

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID SUBSTITUTION [1_546] [1_742] [1_767] TYROSINE O-PHOSPHATE 2R86C98KDX
AMINO ACID SUBSTITUTION [1_563] [1_565] [1_573] [1_700] [1_816] [1_929] [1_943] TYROSINE O-PHOSPHATE 2R86C98KDX
AMINO ACID SUBSTITUTION [1_548] [1_733] [1_967] DEXFOSFOSERINE VI4F0K069V
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966